Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 67Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Leukemia 41Myelodysplastic Syndromes 35Lymphoma, Non-Hodgkin 17Recurrence 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Leukemia, Lymphocytic, Chronic, B-Cell 11Hodgkin Disease 11Congenital Abnormalities 11Lymphoma 10Leukemia, Myelomonocytic, Chronic 10Hematologic Neoplasms 8Leukemia, Biphenotypic, Acute 7Neoplasms 6Multiple Myeloma 6Leukemia, Myelomonocytic, Juvenile 6Burkitt Lymphoma 6Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelomonocytic, Acute 5Leukemia, Monocytic, Acute 5Leukemia, Megakaryoblastic, Acute 5Leukemia, Erythroblastic, Acute 5Graft vs Host Disease 5Anemia, Refractory, with Excess of Blasts 5Lymphoma, Mantle-Cell 4Lymphoma, B-Cell 4Leukemia, Promyelocytic, Acute 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Eosinophilic, Acute 4

Interventions

fludarabine 2Busulfan 2thymoglobulin 1fludarabine phosphate 1bicalutamide 1Testosterone 1Saline Solution 1Powders 1Nutrition Assessment 1Metformin 1Mesna 1Melphalan 1Influenza Vaccines 1Honey 1Heparin 1Gonadotropin-Releasing Hormone 1Gastric Bypass 1Exercise 1Eating 1Cyclophosphamide 1Clofarabine 1Caloric Restriction 1Antineoplastic Agents 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Metabolic Diseases × Clofarabine × Clear all
NCT01596699 2020-02-26

Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

University of California, San Francisco

Phase 2 Terminated
16 enrolled 11 charts

Bone Marrow Failure Disorders, Metabolic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡